Rapid Micro Biosystems, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 17.13 million compared to USD 23.23 million a year ago. Net loss was USD 60.81 million compared to USD 73.52 million a year ago.

Basic loss per share from continuing operations was USD 1.43 compared to USD 3.94 a year ago.